Cargando…

RNA modification in cardiovascular disease: implications for therapeutic interventions

Cardiovascular disease (CVD) is the leading cause of death in the world, with a high incidence and a youth-oriented tendency. RNA modification is ubiquitous and indispensable in cell, maintaining cell homeostasis and function by dynamically regulating gene expression. Accumulating evidence has revea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cong, Hou, Xuyang, Guan, Qing, Zhou, Huiling, Zhou, Li, Liu, Lijun, Liu, Jijia, Li, Feng, Li, Wei, Liu, Haidan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603151/ https://www.ncbi.nlm.nih.gov/pubmed/37884527 http://dx.doi.org/10.1038/s41392-023-01638-7

Ejemplares similares

Epithelial-mesenchymal reprogramming by KLF4-regulated Rictor expression contributes to metastasis of non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2022)

Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells
por: Zhou, Huiling, et al.
Publicado: (2023)

Case Report: Mycobacterium senegalense Infection After Cholecystectomy
por: Zhou, Huiling, et al.
Publicado: (2022)

Editorial: RNA Modification in Human Cancers: Roles and Therapeutic Implications
por: Zhou, You, et al.
Publicado: (2022)

MKI67 as a potential diagnostic biomarker in pulmonary hypertension
por: Zhou, Huiling, et al.
Publicado: (2022)

Successful management of a rare case of juvenile giant right ventricular myxoma
por: Gong, Ke, et al.
Publicado: (2023)

Pathogenesis of allergic diseases and implications for therapeutic interventions
por: Wang, Ji, et al.
Publicado: (2023)

RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage
por: Zhou, Huiling, et al.
Publicado: (2020)

Multilevel regulation of N(6)-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities
por: Feng, Lili, et al.
Publicado: (2022)

The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer
por: Yu, Xinfang, et al.
Publicado: (2022)

RNA modifications in aging-associated cardiovascular diseases
por: Yang, Xinyu, et al.
Publicado: (2022)

Repression of Noxa by Bmi1 contributes to deguelin‐induced apoptosis in non‐small cell lung cancer cells
por: Li, Wei, et al.
Publicado: (2018)

Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
por: Rong, Dawei, et al.
Publicado: (2021)

New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions
por: Guo, Bei, et al.
Publicado: (2020)

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention
por: Ortega, Rebeca, et al.
Publicado: (2023)

RNA modification: mechanisms and therapeutic targets
por: Qiu, Lei, et al.
Publicado: (2023)

The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
por: Li, Gaofeng, et al.
Publicado: (2022)

Histone Modifications and Chondrocyte Fate: Regulation and Therapeutic Implications
por: Wan, Chao, et al.
Publicado: (2021)

Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy
por: Liu, Weiwei, et al.
Publicado: (2022)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
por: Liu, Albert, et al.
Publicado: (2022)

Protein post-translational modification by lysine succinylation: Biochemistry, biological implications, and therapeutic opportunities
por: Zhao, Guo, et al.
Publicado: (2022)

Circadian Rhythms in Cardiovascular Function: Implications for Cardiac Diseases and Therapeutic Opportunities
por: Lin, Jiayue, et al.
Publicado: (2023)

Role of N(6)-Methyladenosine RNA Modification in Cardiovascular Disease
por: Song, Dandan, et al.
Publicado: (2021)

The roles and therapeutic implications of messenger RNA internal N (7)‐methylguanosine and N (6)‐methyladenosine modifications in chemoresistance
por: Zhao, Zhicong, et al.
Publicado: (2023)

Adipose tissue aging: mechanisms and therapeutic implications
por: Ou, Min-Yi, et al.
Publicado: (2022)

Modification of Covalent Triazine-Based Frameworks for Photocatalytic Hydrogen Generation
por: Xie, Jijia, et al.
Publicado: (2022)

Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies
por: Zhu, Li-Ran, et al.
Publicado: (2021)

Role of Posttranslational Modifications of Proteins in Cardiovascular Disease
por: Liu, Yong-Ping, et al.
Publicado: (2022)

The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases
por: Lu, Li, et al.
Publicado: (2022)

Hypoxia signaling in cancer: Implications for therapeutic interventions
por: Zhuang, Yan, et al.
Publicado: (2023)

Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration
por: Wang, Jia-Jian, et al.
Publicado: (2018)

RNA Motifs and Modification Involve in RNA Long-Distance Transport in Plants
por: Wang, Tao, et al.
Publicado: (2021)

Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets
por: Shu, Feng, et al.
Publicado: (2023)

Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
por: Hua, Cun-Cun, et al.
Publicado: (2022)

Microbiota in cancer: molecular mechanisms and therapeutic interventions
por: Chen, Zhou, et al.
Publicado: (2023)

The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases
por: Liu, Jinlin, et al.
Publicado: (2021)

Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine
por: Li, Hua, et al.
Publicado: (2017)

Spatial Variation in Bacterioplankton Communities in the Pearl River, South China: Impacts of Land Use and Physicochemical Factors
por: Zhou, Lei, et al.
Publicado: (2020)

Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization
por: Gao, Feng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lipnjkrs56a4lhsf00a11d1q2c